• Mashup Score: 0
    Modern Retina - 2 year(s) ago

    July 15, 2022 ByEmily Kaiser, David HuttonAt ASRS in New York City, Charles Wykoff, MD, presented a talk entitled, “Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study.” The trial demonstrated large improvements for patients with diabetic macular edema (DME) and non-proliferative diabetic retinopathy (NPDR), with notable improvements according to the…

    Tweet Tweets with this article
    • We are thrilled to have Dr. Eichenbaum moderate our breakfast roundtable in NYC this morning, where retina specialists met and shared their expertise on the treatment strategies for AMD and DME. Highlights are to be published on https://t.co/wLY0Q5D4op soon! #ASRS2022 #retina https://t.co/HRHb2ZQ8z0

  • Mashup Score: 2
    ASRS - 3 year(s) ago

    Determining the time to DME resolution with intravitreal afliberceptOctober 09, 2021ByLynda ChartersSpeaking at the American Society of Retina Specialists 2021 annual meeting in San Antonio, Rishi P. Singh, MD, provided results of the VISTA and VIVID studies, and he pointed out that the findings could help physicians set expectations of DME therapy. Faricimab in DME: Results from phase 3 YOSEMITE…

    Tweet Tweets with this article
    • Our sister publications @ModernRetina and @OTEurope are covering #ASRS2021! Check out the coverage: https://t.co/EDA2bf2gwV and https://t.co/SYl6RfidEM #Ophthalmology @asrsdocs #Retina #ASRS https://t.co/LNeNS683tN

  • Mashup Score: 0

    undefined | Page 2

    Tweet Tweets with this article
    • How has the @aao_ophth's IRIS Registry benefited clinicians and patients so far? What's the potential of gene therapy for exudative #AMD patients? Learn that and more by exploring the expert-curated Wet AMD resource center now. #retina #ophthalmology https://t.co/svDHdL23tI https://t.co/DIVeHaQMvg

  • Mashup Score: 0

    undefined | Page 2

    Tweet Tweets with this article
    • How has the @aao_ophth's IRIS Registry benefited clinicians and patients so far? What's the potential of gene therapy for exudative #AMD patients? Learn that and more by exploring the expert-curated Wet AMD resource center now. #retina #ophthalmology https://t.co/svDHdL23tI https://t.co/gsCYuJgKNv

  • Mashup Score: 0

    undefined

    Tweet Tweets with this article
    • How has the @aao_ophth's IRIS Registry benefited clinicians and patients so far? What's the potential of gene therapy for exudative #AMD patients? Learn that and more by exploring the expert-curated Wet AMD resource center now. #retina #ophthalmology https://t.co/svDHdL23tI https://t.co/llYLGvtXNQ

  • Mashup Score: 0

    undefined

    Tweet Tweets with this article
    • How has the @aao_ophth's IRIS Registry benefited clinicians and patients so far? What's the potential of gene therapy for exudative #AMD patients? Learn that and more by exploring the expert-curated Wet AMD resource center now. #retina #ophthalmology https://t.co/svDHdL23tI https://t.co/30Cb0V5ahk